miR-195-5p acts as a tumor suppressor in tumor progression by targeting numerous genes, such as YAP1 in CRC [29], RPS6KB1 in prostate cancer [35], MMP14 in cervical carcinoma [36], and NOTCH2 in osteosarcoma [12]. Here, YAP1 is linked to prostate cancer.